Equity Digest Stock Directory

Green EnviroTech Holdings Corp. (GETH.PK) tire and plastic to oil sample accepted by a Major Oil Company for purchase.Green EnviroTech Holdings, Corp.

May 14, 2012 /PRNewswire/ -- Green EnviroTech Holdings Corp. (GETH.PK) announces today that the tire and plastic to oil samples sent to a major oil company have been accepted as a quality that they will purchase. The oil company stated that their lab results showed all of the qualities of the crude oil samples received to be within typical specifications for their refinery. CEO Gary M De Laurentiis stated, "This is another huge leap forward for GETH and our tire and plastic to oil project with Ebbros Energy LLC. This is the final piece of what was needed to move forward with our first plant. We are finalizing our agreement with Ebbros so we can move from the non-binding LOI to a finance and purchase agreement next week. Terms of a purchase agreement between Ebbros and the oil company are now being negotiated as to the delivery point and financial terms. We anticipate the contract to be completed in the next few weeks."

Vycor Medical, Inc. Reports First Quarter 2012 Results
Revenue up 198% Over First Quarter 2011; Vycor Medical Division Revenue up 222% Over 2011, NovaVision Division up 145%; Net Loss Reduced

BOCA RATON, FL, May 16, 2012 (MARKETWIRE via COMTEX) -- Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) yesterday reported first quarter 2012 revenue of $432,601, a 198% increase on the $145,122 for the first quarter of 2011. The Vycor Medical division generated revenue of $321,781, a 222% increase on 2011, and NovaVision generated revenue of $110,820, a 145% increase, including a maiden contribution from Sight Science. Gross profit for the first quarter of 2012 was $353,179 compared to $122,749 in 2011. The overall group margin was slightly lower at 82% in 2012 compared to 85% in 2011.

NVLX OTC BB Nuvilex Inc

PLPL OTC Plandaí Biotechnology, Inc. NBT starts coverage on Plandai Biotechnology, Inc. (PLPL)

Initiating Coverage on Plandai Biotechnology, Inc. (PLPL) with Speculative Buy $2.50 Target or 10X Upside from Current .25 Share

NBT starts coverage on Plandai Biotechnology, Inc. (PLPL) NBT starts coverage on Plandai Biotechnology, Inc. (PLPL) with Speculative Buy $2.50 target because they are about to bring a super high dosage (i.e. up to 8X the “good stuff” in your body from ONE serving) green tea extract to the $50 billion global tea market.

We have followed Plandai’s quest for many years, and are excited to announce they are NOW less than a year away from the holy grail of green tea—60-80% bioavailable/absorbable green tea extract.

SEGI OTC Sycamore Entertainment Group, Inc.